Pharmaceuticals Press Releases
Breaking News
-
The NU-Life Cosmetics Cellulite Cream Questioned
Learn more about the NU-Life Cosmetics Cellulite Cream to see if it can help you. /EINPresswire.com/ The NU-Life Cosmetics Thigh & Stomach Cream (cellulite cream) has drawn some negative responses within the Anti-aging community, there...
-
The problem of steroid resistance in Asthma & COPD
/EINPresswire.com/ The similarities between the two conditions are juxtaposed with the subtle and important differences. Both pose unique and complex challenges, and these differences must be identified and isolated. As respiratory research...
-
Molecular obesity, potency and other addictions in medicinal chemistry
/EINPresswire.com/ SMi's Drug Design Conference will aim to address many of the challenging issues faced by the pharmaceutical industry in drug design. Key selected industry experts will provide you with timely and up-to-date information on...
-
EIN News Announces Launch of Cephalon Daily Report
Washington, January 30, 2012 /EINPresswire.com/ EIN News, a leading media monitoring company focused on political, business and industry news, has added Cephalon Daily Report to its Company Daily Reports news division. For more news see: -...
-
Maximise manufacturing efficiency and scale-ability for miniaturisation and bead milling
/EINPresswire.com/ With 2 months to go join SMi at their 9th annual Controlled Release conference to be held on the 28th & 29th March 2012 London. This must-attend event will once again lead the way in examining the latest developments in nanomedicine...
Press Releases
Pharmaceuticals
-
Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid Arthritis
Benitec Biopharma (ASX: BLT) and Medistem (PINKSHEETS: MEDS) announced today the successful treatment of rheumatoid arthritis in preclinical models using Benitec Biopharma's patented gene silencing technology applied to stem cell-derived immune...
-
Express Scripts, Inc. Announces Pricing of $3.5 Billion Senior Notes Offering
Express Scripts, Inc. Announces Pricing of $3.5 Billion Senior Notes Offering PR Newswire ST. LOUIS , Feb. 6, 2012 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that its wholly owned subsidiary,...
-
Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2011 Results
Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2011 Results PR Newswire CRANBURY, N.J. , Feb. 6, 2012 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), the leading Specialty Phosphates...
-
Cardinal Health Canada Inc. and Futuremed Announce Further Extension of Offer
Cardinal Health Canada Inc. and Futuremed Announce Further Extension of Offer PR Newswire TORONTO , Feb. 6, 2012 /PRNewswire/ -- Futuremed Healthcare Products Corporation (" Futuremed ") (TSX: FMD) and Cardinal Health...
-
OphthaliX Announces the Appointment of Prof. Roger Kornberg as a Director
OphthaliX Announces the Appointment of Prof. Roger Kornberg as a Director PR Newswire CARSON CITY, Nev. , Feb. 6, 2012 /PRNewswire/ -- OphthaliX Inc. (OTCBB: OPLI) is pleased to announce the appointment of Professor Roger D. Kornberg...
-
Dietary Supplements Extensively Regulated, Say Authors of New Article
Dietary Supplements Extensively Regulated, Say Authors of New Article PR Newswire American Botanical Council Publishes Article Documenting the Regulation of Herbs and Other Supplements AUSTIN, Texas , Feb. 6, 2012...
-
BioMed Realty Trust to Acquire Cambridge Place For $119 Million
BioMed Realty Trust to Acquire Cambridge Place For $119 Million Acquisition will expand total Boston/Cambridge, Massachusetts portfolio to approximately 3.2 million square feet PR Newswire SAN...
-
Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection
Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection PR Newswire SAN DIEGO , Feb. 6, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical...
-
Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference LIVE AUDIO WEBCAST MONDAY, FEBRUARY 13, 2012 PR Newswire SAN DIEGO , Feb. 6, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc....
-
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results Strategic Execution, Fiscal Discipline in 2011 Yield Non-GAAP Operating Income of $26 Million PR Newswire SAN DIEGO , Feb. 6, 2012 /PRNewswire/ --...
-
Cambrex Reports Fourth Quarter and Full Year 2011 Results
Cambrex Reports Fourth Quarter and Full Year 2011 Results PR Newswire EAST RUTHERFORD, N.J. , Feb. 6, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) reports fourth quarter and full year results for the period ended December...
-
'Camera in a Pill' Endoscopy Sees Increasing Acceptance and Sales
Driven by innovative devices such as capsule endoscopes, the entire gastrointestinal device market grew to $14.6 billion in 2011, according to healthcare market research publisher Kalorama Information. Capsule endoscopy has been one of the fastest...
-
Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results
Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results Luminex achieves 30 percent annual revenue growth PR Newswire AUSTIN, Texas , Feb. 6, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced...
-
Neurelis Announces FDA Allowance of IND Application for NRL-1, a Novel Intranasal Diazepam Formulation
Neurelis Announces FDA Allowance of IND Application for NRL-1, a Novel Intranasal Diazepam Formulation Acceptance of Investigational New Drug Application is another significant milestone in the effort to address the significant need for a...
-
Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference
Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference PR Newswire EAST RUTHERFORD, N.J. , Feb. 6, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Greg Sargen , Executive...
Follow us
What people say
Our Partners
© 2005-2012